Resources
BNET Resources
- sort by:
- Relevance
- Date
- Popularity
- Five Reason Repros Therapeutics Is Hitting 52-Week Highs
- Elliot Eisenberg submits: Five reasons Repros Therapeutics RPRX is hitting 52-week highs: 1. Rare among biotechs, its funding needs have been met. Last year, Repros agreed with Efficacy Capital to allow the fund to buy up to 40 percent of...
- External links 2009-01-09
- Why OpNext Is Likely to Outperform
- Elliot Eisenberg submits: OpNext OPXT is a producer of equipment used to transmit voice and data along fiber optic cable networks. After the close of business January 9, it concluded the acquisition of StrataLight Communications for $30 million cash and 26.5 million shares of OPXT common. The...
- External links 2009-01-12
- Behind Korea's Bearish Call on Treasurys
- Elliot Eisenberg submits: Much was said this week when a Korean pension official made a bearish call on US Treasury bonds. The Wall Street Journal highlighted the comment on January 19 when it reported: by Elliot Eisenberg
- External links 2009-01-21
- How John Thain Lost $15 Billion
- Elliot Eisenberg submits: The John Thain tenure at Merrill/Bank of America BAC ended yesterday, done in according to CNBC and other report by over $1 million in interior design expenditures for his New York office, and $15 billion in losses in the fourth quarter. It has mystified some how Merrill...
- External links 2009-01-23
- Why Michelle Obama Is Likely to Support Repros Therapeutics
- Elliot Eisenberg submits: The nation's First Lady is attractive, accomplished, happily married and the mother of two young girls. At the University of Chicago Medical Center, she had managerial experience in a major hospital system. She is also black. by Elliot Eisenberg
- External links 2009-07-12
- << Previous
- page 1 of 1
- Next >>
